Assessment and management in adults and young people: surveillance review proposal information
History
Documents created during the development process.
Review documents
-
-
Assessment and management in adults and young people: review proposal
-
Assessment and management in adults and young people: review proposal (PDF 333 KB)
-
Assessment and management in adults and young people: list of registered stakeholders February 2015
-
-
Surveillance review decision March 2015
-
Other information
-
Evidence update
-
Background information
Psychosis with substance misuse: stakeholder list and how to register
-
Psychosis with substance misuse: list of stakeholders
-
Psychosis with substance misuse: list of stakeholders (PDF 46 KB)
Psychosis with substance misuse: scoping workshop, consultation and final scope
-
Psychosis with substance misuse: scoping workshop, consultation and final scope
-
Psychosis with substance misuse: scope consultation information
-
Psychosis with substance misuse: scope comments table
-
Psychosis with substance misuse: scope comments table (PDF 229 KB)
-
Psychosis with substance misuse: final scope
-
Psychosis with substance misuse: guideline development and consultation
-
Psychosis with substance misuse: guideline development and consultation
-
Psychosis with substance misuse: guideline consultation information
-
Psychosis with substance misuse: guideline consultation - full guideline for consultation
-
-
Psychosis with substance misuse: guideline consultation - full guideline appendices
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 13
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 13 (PDF 360 KB)
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 14
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 14 (PDF 2.01 MB)
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 15
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 15 (PDF 334 KB)
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 16
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 16 (PDF 621 KB)
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 17
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 17 (PDF 103 KB)
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 18
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 18 (PDF 152 KB)
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 19
-
Psychosis with substance misuse: guideline consultation - full guideline appendix 19 (PDF 157 KB)
-
Psychosis with substance misuse: guideline consultation - NICE guideline for consultation
-
-
Psychosis with substance misuse: list of stakeholders
-
Psychosis with substance misuse: list of stakeholders (PDF 46 KB)
-
Psychosis with substance misuse: GDG membership list
-
Psychosis with substance misuse: GDG membership list (PDF 14 KB)
-
Psychosis with substance misuse: minutes for GDG meetings
-
Psychosis with substance misuse: GDG 1 - minutes
-
Psychosis with substance misuse: GDG 1 - minutes (PDF 19 KB)
-
Psychosis with substance misuse: GDG 2 - minutes
-
Psychosis with substance misuse: GDG 2 - minutes (PDF 16 KB)
-
Psychosis with substance misuse: GDG 3 - minutes
-
Psychosis with substance misuse: GDG 3 - minutes (PDF 16 KB)
-
Psychosis with substance misuse: GDG 4 - minutes
-
Psychosis with substance misuse: GDG 4 - minutes (PDF 16 KB)
-
Psychosis with substance misuse: GDG 5 - minutes
-
Psychosis with substance misuse: GDG 5 - minutes (PDF 16 KB)
-
Psychosis with substance misuse: GDG 6 - minutes
-
Psychosis with substance misuse: GDG 6 - minutes (PDF 16 KB)
-
Psychosis with substance misuse: GDG 7 - minutes
-
Psychosis with substance misuse: GDG 7 - minutes (PDF 17 KB)
-
Psychosis with substance misuse: GDG 8 and 9 - minutes
-
Psychosis with substance misuse: GDG 8 and 9 - minutes (PDF 21 KB)
-
Psychosis with substance misuse: equalities impact assessment (recommendations)
-
Psychosis with substance misuse: equalities impact assessment (recommendations) (PDF 70 KB)
-
Psychosis with substance misuse: final consultation comments with developer's responses table
-
Psychosis with substance misuse: pre-publication check
-
Psychosis with substance misuse: pre-publication check information
-
Psychosis with substance misuse: pre-publication check - error reporting table
-
Psychosis with substance misuse: pre-publication check - error reporting table (PDF 93 KB)
-
Psychosis with substance misusue: pre-publication check - full guideline
-
Psychosis with substance misusue: pre-publication check - full guideline (PDF 2.88 MB)
-
Psychosis with substance misusue: pre-publication check - full guideline appendices
-
Psychosis with substance misusue: pre-publication check - full guideline appendix 13, clinical study characteristics
-
-
Psychosis with substance misusue: pre-publication check - full guideline appendix 14, forest plots
-
-
Psychosis with substance misusue: pre-publication check - full guideline appendix 15, grade evidence profiles
-
-
Psychosis with substance misusue: pre-publication check - full guideline appendix 16, methodology checklists
-
-
Psychosis with substance misusue: pre-publication check - full guideline appendix 17, economic evidence profiles
-
-
Psychosis with substance misusue: pre-publication check - full guideline appendix 18, economic methodoloogy checklist
-
-
Psychosis with substance misusue: pre-publication check comments form
-
Psychosis with substance misusue: pre-publication check comments form (MSWord 55 KB)
-
Psychosis with substance misusue: pre-publication check consultation tables with developer's responses
-
Severe mental illness with problematic substance misuse: remit
-
Severe mental illness with problematic substance misuse: remit
-
Severe mental illness with problematic substance misuse: remit (PDF 11 KB)